About Company
- Legal Name: Transo-Pharm Handels GmbH
- Registered country: Germany
- Address: Bueltbek 5, 22962 Siek
- Number of employees: 25 - 49
Description:
Transo-Pharm, founded in 1987, is a fully licensed global distributor of pharmaceutical components for health and veterinary industries. It supports customers throughout the API lifecycle, from development to sales, offering diverse products and qualifying manufacturers for compliance. Acting as a sourcing and regulatory marketing agent, Transo-Pharm has offices in Shanghai, Hong Kong, Singapore, the United States, and an affiliated office in Mumbai. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Business Activities
Active Pharmaceutical Ingredients (APIs)
DistributorLogistics UnitRegulatory Consultant
ATC (Anatomical Therapeutic Chemical) Classification
DistributorLogistics UnitRegulatory Consultant
Innovator APIs
DistributorLogistics UnitRegulatory Consultant
Regulatory & Market Intelligence Services
Service Provider
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Hyoscine N-Butylbromide (CEP), Ajmaline (ASMF), Noscapine (ASMF), Scopolamine Hydrobromide (CEP / US-DMF), Scopolamine Methylbromide (US-DMF), Doxorubicin HCl (CEP), Epirubicin HCl ( CEP / US-DMF), Idarubicin HCl (ASMF / US-DMF), Nelarabine (US-DMF), Valrubicin (US-DMF), Epinephrine Base (CEP / US-DMF), Epinephrine Bitartrate (CEP / US-DMF), Estriol (CEP), Norepinephrine bitartrate (CEP / US-DMF), Thyroid Extract (USP), Dorzolamide HCl (CEP), Acetylcysteine (CEP), Crotamiton (CEP / US-DMF), Dexmedetomidine (ASMF), Guaifenesin (CEP / US-DMF), Hyoscine (CEP), Levosimendan (ASMF), Methocarbamol (ASMF / US-DMF), Nonivamide (ASMF), Phenylephrine HCl (CEP / US-DMF), Tranexamic Acid (CEP)
- Innovator APIs: Digoxin (CEP / US-DMF)
- Veterinary Pharmaceuticals & Feed Additives: Clenbuterol HCl (CEP / US-VMF)
Our Products & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
CEP Certificate
DMF
GMP
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment